AP Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16,687	15,320	4,223	3,017	-	-
Market Cap Growth	256.99%	262.77%	39.97%	-	-	-
Enterprise Value	15,575	14,109	2,559	2,131	-	-
Last Close Price	195.00	180.00	49.75	46.60	-	-
PS Ratio	-	-	-	93.55	-	-
PB Ratio	13.13	12.05	2.60	3.85	-	-
P/TBV Ratio	13.16	12.08	2.61	3.87	-	-
EV/Sales Ratio	-	-	-	66.08	-	-
Debt / Equity Ratio	0.05	0.05	0.04	0.11	-	-
Net Debt / Equity Ratio	-0.87	-0.87	-0.91	-0.84	-0.98	-1.00
Net Debt / EBITDA Ratio	2.51	2.51	3.39	1.91	3.72	3.12
Net Debt / FCF Ratio	2.95	2.95	4.05	1.98	3.89	3.23
Asset Turnover	-	-	-	0.03	-	0.01
Quick Ratio	29.73	29.73	39.77	24.77	241.91	26.35
Current Ratio	29.94	29.94	39.87	24.80	242.10	26.67
Return on Equity (ROE)	-30.74%	-30.74%	-35.13%	-36.04%	-34.83%	-31.24%
Return on Assets (ROA)	-18.45%	-18.45%	-20.96%	-21.78%	-22.10%	-18.95%
Return on Capital Employed (ROCE)	-34.50%	-34.50%	-26.00%	-40.40%	-27.10%	-33.50%
Earnings Yield	-2.67%	-2.90%	-10.01%	-11.24%	-	-
FCF Yield	-2.26%	-2.46%	-8.61%	-11.03%	-	-
Buyback Yield / Dilution	-13.06%	-13.06%	-16.28%	-22.98%	-118.32%	-75.62%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.